Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Biochemical Engineering>Inhibitors>DNA damage>PARP inhibitors>Olaparib
Olaparib
  • Olaparib
  • Olaparib
  • Olaparib
  • Olaparib
  • Olaparib

Olaparib NEW

Price Get Latest Price
Package 1kg
Min. Order: 1kg
Supply Ability: 10000kg
Update Time: 2024-04-13

Product Details

Product Name: Olaparib CAS No.: 763113-22-0
EC-No.: 642-941-5 Min. Order: 1kg
Purity: 99% Supply Ability: 10000kg
Release date: 2024/04/13

Manufacturer Provide Best Olaparib Powder Price CAS 763113-22-0 99% Olaparib

Article illustration

Introduction

Product Name: Olaparib

Other Name :4-(3-(4-(cyclopropanecarbonyl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one

CAS NO:763113-22-0

Purity: 99%min
Appearance:White crystalline powder

Molecular formula:C24H23FN4O3

MW:434.46

Density :1.43

Storage :Keep in dark place,Inert atmosphere,Room temperature


Olaparib is a new type of poly ADP ribose polymerase (PARP) inhibitor, including PARP1, PARP2, and PARP3. PARP mediated a DNA repair mechanism, plays an important role in DNA damage repair and apoptosis, so Ola Pani specific effect on target cell DNA damage repair mechanism, by attacking the carrying BRCA1 and BRCA2 mutation critical vulnerabilities in cancer cells play a role, can be used for breast cancer susceptibility gene (BRCA) mutation and for the maintenance treatment of platinum sensitive recurrent severe ovarian cancer patients.


Application

Olaparib is an anti-tumor targeted therapy drug, which kills cancer cells mainly by synthesizing a lethal mechanism. It is mainly used clinically for the treatment of advanced epithelial ovarian cancer.
Olaparib is an inhibitor of poly (ADP-ribose) polymerase (PARP) enzymes, including PARP1, PARP2, and PARP3. PARP enzymes are involved in normal cellular homeostasis, such as DNA transcription, cell cycle regulation, and DNA repair. Olaparib has been shown to inhibit growth of select tumor cell lines in vitro and decrease tumor growth in mouse xenograft models of human cancer both as monotherapy or following platinum-based chemotherapy. Increased cytotoxicity and anti-tumor activity following treatment with olaparib were noted in cell lines and mouse tumor models with deficiencies in BRCA. In vitro studies have shown that olaparib-induced cytotoxicity may involve inhibition of PARP enzymatic activity and increased formation of PARP-DNA complex, resulting in disruption of cellular homeostasis and cell death.

Article illustration



Company Profile Introduction

Shaanxi TNJONE Pharmaceutical Co., Ltd supplies more than 2,000 kinds of products, covering the whole field of health industry, including human APIs, veterinary APIs, food additives, natural nutrition ingredients, feed additives, cosmetic additives, intermediates etc. With global sourcing advantages, the group is fully capable of meeting the one-stop sourcing needs of global customers. Today, Shaanxi TNJONE Pharmaceutical Co., Ltd.'s marketing network has spread over more than 100 countries and regions on five continents, providing professional service for global customers.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$10.60/1KG
VIP4Y
Hebei Chuanghai Biotechnology Co,.LTD
2024-08-20
$0.00/1g
VIP1Y
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
2024-07-23
$0.00/25kg
VIP1Y
PUSHAN INDUSTRIAL (SHAANXI) CO.,LTD
2024-05-15
$15.00/1kg
Ouhuang Engineering Materials (Hubei) Co., Ltd
2024-04-26
$1.00/1g
VIP4Y
Dorne Chemical Technology co. LTD
2024-03-26
$0.00/1kg
VIP1Y
Shandong Hanjiang Chemical Co., Ltd
2024-01-19
$0.00/1kg
VIP1Y
Nanjing Fred Technology Co., Ltd
2023-12-27
$70.00/1kg
VIP2Y
Zibo Hangyu Biotechnology Development Co., Ltd
2023-11-20
$10.00/1kg
VIP1Y
Nantong Guangyuan Chemicl Co,Ltd
2023-11-03
$65.00/1kg
VIP1Y
Wuhan Quanjinci New Material Co.,Ltd.
2023-10-20

Shaanxi TNJONE Pharmaceutical Co., Ltd

1YR ChinaChina
  • Since: 2019-05-23
  • Address: No. 4C-11-A392, Financial Port, Northwest corner of Fengjing Avenue and Fengxin Road, Fengdong New C
INQUIRY